Pseudomonas aeruginosa

Last updated: November 01, 2022

Pseudomonas aeruginosa

MSKD

MSKD

Bones of the vertebral column
Vessels and nerves of the vertebral column
Joints of the vertebral column
Muscles of the back
Anatomy of the vertebral canal
Anatomy clinical correlates: Vertebral canal
Anatomy clinical correlates: Spinal cord pathways
Anatomy clinical correlates: Bones, joints and muscles of the back
Anatomy of the suboccipital region
Ectoderm
Endoderm
Mesoderm
Development of the axial skeleton
Development of the nervous system
Central nervous system histology
Peripheral nervous system histology
Glucocorticoids
Opioid agonists, mixed agonist-antagonists and partial agonists
Non-steroidal anti-inflammatory drugs
Opioid antagonists
Carpal tunnel syndrome
Opioid use disorder
Spinal disc herniation
Degenerative disc disease
Back pain: Pathology review
Lower back pain: Clinical
Sympathetic nervous system
Parasympathetic nervous system
Introduction to the skeletal system
Introduction to the muscular system
Anatomical terminology
Anatomy of the pelvic girdle
Arteries and veins of the pelvis
Nerves and lymphatics of the pelvis
Bones of the lower limb
Fascia, vessels and nerves of the lower limb
Anatomy of the anterior and medial thigh
Muscles of the gluteal region and posterior thigh
Vessels and nerves of the gluteal region and posterior thigh
Anatomy of the popliteal fossa
Anatomy of the leg
Anatomy of the foot
Anatomy of the hip joint
Anatomy of the knee joint
Anatomy of the tibiofibular joints
Joints of the ankle and foot
Glycolysis
Glycogen metabolism
Gluconeogenesis
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Glycogen storage disease type I
Glycogen storage disease type III
Glycogen storage disease type V
Glycogen storage disease type IV
Glycogen storage disease type II (NORD)
Glycogen storage disorders: Pathology review
Cytoskeleton and intracellular motility
Osteogenesis imperfecta
Marfan syndrome
Ehlers-Danlos syndrome
Development of the limbs
Development of the muscular system
Achondroplasia
Myotonic dystrophy
Muscular dystrophy
Mitochondrial myopathy
Muscular dystrophies and mitochondrial myopathies: Pathology review
Bone histology
Skeletal muscle histology
Cartilage histology
Winged scapula
Klumpke paralysis
Erb-Duchenne palsy
Unhappy triad
Anterior cruciate ligament injury
Meniscus tear
Sprained ankle
Achilles tendon rupture
Spondylolysis
Spondylolisthesis
Pectus excavatum
Osteoporosis
Osteopetrosis
Osteomalacia and rickets
Lordosis, kyphosis, and scoliosis
Paget disease of bone
Osteoarthritis
Bursitis
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Bone disorders: Pathology review
Spina bifida
Osteoporosis medications
Skeletal system anatomy and physiology
Cartilage structure and growth
Bone remodeling and repair
Fibrous, cartilage, and synovial joints
Muscular system anatomy and physiology
Brachial plexus
Neuromuscular junction and motor unit
Sliding filament model of muscle contraction
Slow twitch and fast twitch muscle fibers
Muscle contraction
Muscle spindles and golgi tendon organs
Neuron action potential
Bones of the upper limb
Fascia, vessels and nerves of the upper limb
Anatomy of the brachial plexus
Anatomy of the pectoral and scapular regions
Anatomy of the arm
Muscles of the forearm
Vessels and nerves of the forearm
Muscles of the hand
Anatomy of the sternoclavicular and acromioclavicular joints
Anatomy of the glenohumeral joint
Anatomy of the elbow joint
Anatomy of the radioulnar joints
Joints of the wrist and hand
Anatomy of the axilla
Anatomy clinical correlates: Clavicle and shoulder
Anatomy clinical correlates: Axilla
Anatomy clinical correlates: Arm, elbow and forearm
Anatomy clinical correlates: Wrist and hand
Anatomy clinical correlates: Median, ulnar and radial nerves
Vitamin C deficiency
Nucleotide metabolism
Lesch-Nyhan syndrome
Adenosine deaminase deficiency
Orotic aciduria
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Staphylococcus epidermidis
Staphylococcus aureus
Streptococcus pyogenes (Group A Strep)
Streptococcus agalactiae (Group B Strep)
Streptococcus pneumoniae
Clostridium perfringens
Pseudomonas aeruginosa
Bacteroides fragilis
Neisseria gonorrhoeae
Mycobacterium tuberculosis (Tuberculosis)
Chlamydia trachomatis
Borrelia burgdorferi (Lyme disease)
Histoplasmosis
Candida
Miscellaneous cell wall synthesis inhibitors
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
Osgood-Schlatter disease (traction apophysitis)
Rotator cuff tear
Dislocated shoulder
Radial head subluxation (Nursemaid elbow)
Thoracic outlet syndrome
Ulnar claw
Iliotibial band syndrome
Patellar tendon rupture
Patellofemoral pain syndrome
Sciatica
Compartment syndrome
Rhabdomyolysis
Cleidocranial dysplasia
Osteomyelitis
Bone tumors
Chondrosarcoma
Osteochondroma
Spondylosis
Spinal stenosis
Rheumatoid arthritis
Juvenile idiopathic arthritis
Gout
Calcium pyrophosphate deposition disease (pseudogout)
Psoriatic arthritis
Ankylosing spondylitis
Reactive arthritis
Spondylitis
Septic arthritis
Baker cyst
Polymyositis
Dermatomyositis
Inclusion body myopathy
Polymyalgia rheumatica
Fibromyalgia
Rhabdomyosarcoma
Sjogren syndrome
Raynaud phenomenon
Mixed connective tissue disease
Scleroderma
Systemic lupus erythematosus
Rheumatoid arthritis and osteoarthritis: Pathology review
Gout and pseudogout: Pathology review
Scleroderma: Pathology review
Sjogren syndrome: Pathology review
Systemic lupus erythematosus (SLE): Pathology review
Seronegative and septic arthritis: Pathology review
Myalgias and myositis: Pathology review
Neuromuscular junction disorders: Pathology review
Bone tumors: Pathology review
Benign hyperpigmented skin lesions: Clinical
Seborrhoeic dermatitis
Atopic dermatitis
Contact dermatitis
Blistering skin disorders: Clinical
Skin cancer: Clinical
Papulosquamous skin disorders: Clinical
Alopecia: Clinical
Hypopigmentation skin disorders: Clinical
Hair, skin and nails
Pediatric infectious rashes: Clinical
Eczematous rashes: Clinical
Skin cancer

Transcript

Watch video only

Content Reviewers

Pseudomonas aeruginosa, or P. aeruginosa, is a gram-negative bacterium that is abundant in the environment.

It tends to opportunistically infect high-risk individuals, and is well known for its multi-drug resistance, making it hard to treat.

P. aeruginosa is an encapsulated, gram-negative, rod bacterium, that’s an obligate aerobe, so it uses oxygen for metabolism through cellular respiration.

It does not ferment lactose and does not make spores; but it’s catalase, citrate, and oxidase positive.

It has a flagellum, kind of like a tail, at one end for motility; and has multiple hair-like appendages, called pili, all over that help with adhesion to other cells.

It also has a number of multidrug efflux pumps that efficiently pump medications out of the bacteria making it resistant to a variety of antibiotics.

In addition it’s able to make beta-lactamases that degrade beta-lactam antibiotics as well as aminoglycoside-modifying enzymes that alter aminoglycoside antibiotics - rendering them ineffective. In short, it’s defenses are strong.

P. aeruginosa is everywhere in the environment - in soil; in the home, and in hospitals - where it’s found on improperly cleaned medical equipment and devices, various surfaces, and on the hands of health care workers.

It can survive for months on dry surfaces and inanimate objects – but particularly loves humid or wet conditions; like hot tubs, contact lens cases, catheters, and medical ventilators.

Transmission can occur when broken skin or mucous membranes come in contact with contaminated surfaces; or when aerosols containing P. aeruginosa are inhaled after an infected person coughs or sneezes.

Now, a P. aeruginosa infection is actually not too common in the general population.

It’s an opportunistic bacterium, meaning that it frequently causes infections in high-risk individuals like those with cystic fibrosis, chronic granulomatous disease, and type 2 diabetes mellitus.

It’s also common among individuals with an immunodeficiency; IV drug abusers, or those with severe burns or deep wounds.

P. aeruginosa produces several virulence factors to help it invade epithelial cells and survive an attack from the immune system.

First, there’s endotoxin, a molecule that’s made up of a lipid and polysaccharide.

The endotoxin sits on the outer membrane of the bacteria, and it’s recognized by the immune system as being foreign and causes a really strong immune reaction that can cause extensive damage to the host cells.

Certain strains of P. aeruginosa also produce a mucoid exopolysaccharide capsule, and this contributes to the formation of a biofilm - a slimy, sticky, gummy material – that surrounds colonies of P. aeruginosa and acts like a shield to protect the bacteria from immune cells as well as antibiotics.

P. aeruginosa can also produce toxins that can be injected directly into the host epithelial cells through a type III secretion system.

It’s kind of like a fine needle that pierces the host cell and forms a tunnel between the P. aeruginosa and the host epithelial cell, allowing toxins to pass through.

P. aeruginosa also releases toxins into the extracellular environment.

For example, it releases phospholipase C which is an enzyme that degrades the host cell membrane causing the cell to lyse.

Other secreted toxins have to move within the cell to act.

For example, exotoxin A is released by P. aeruginosa into the extracellular environment and then taken up by nearby host cells where it targets ADP-ribosylation of elongation factor 2, which is a ribosomal protein.

Key Takeaways

Pseudomonas aeruginosa is an aerobic, gram-negative, rod-shaped bacterium commonly found in the environment, such as in soil, in the home, and in hospitals. It is known to opportunistically infect immunocompromised people, and for its multi-drug resistance that is hard to treat.

It is also known to form biofilms that provide it with extra protection against antibiotics on top of its preexisting multi-drug resistance. P. aeruginosa can cause a variety of infections, including urinary tract infections, wound infections, sepsis, and lung infections in people with cystic fibrosis. Treatment for P. aeruginosa infections is with antibiotics, such as aminoglycosides, carbapenems, and cephalosporins.